{"id":{"repo_id":"ohiolink","oai_identifier":"oai:etd.ohiolink.edu:case1354824891"},"canonical_url":"https://search.dev.ndltd.org/etd/ohiolink/oai:etd.ohiolink.edu:case1354824891","repository":{"repo_id":"ohiolink","name":"OhioLINK","base_url":"https://etd.ohiolink.edu/acprod/odb_etd/ws/oai/oai"},"display":{"title":"HeartLander Surgical Feasibility and Commercialization","abstract":"It is shown that ventricular tachycardia ablation via the HeartLander Surgical robot is a commercially feasible method for relieving patients from arrhythmia symptoms. HeartLander’s technology meets significant market needs presented by the 450,000 sudden cardiac deaths each year; many were patients for whom ablation was not an option. HeartLander’s robotic platform provides significant benefits per cost savings for hospitals and insurance companies, and significantly reduces VT ablation procedure times. HeartLander’s product shows the potential for both commercial and academic impact by revolutionizing epicardial access. Device and procedural specifications along with the underlying physics of needle ablation prove the feasibility of the technology. The regulatory hurdles, human use, and milestones for scaling up to clinical trials are all addressed in the commercialization of the surgical platform. Beyond the indicated use of VT ablation, HeartLander can look toward existing practices and developing regenerative therapies for expanding its customer base.","abstract_html":"It is shown that ventricular tachycardia ablation via the HeartLander Surgical robot is a commercially feasible method for relieving patients from arrhythmia symptoms. HeartLander’s technology meets significant market needs presented by the 450,000 sudden cardiac deaths each year; many were patients for whom ablation was not an option. HeartLander’s robotic platform provides significant benefits per cost savings for hospitals and insurance companies, and significantly reduces VT ablation procedure times. HeartLander’s product shows the potential for both commercial and academic impact by revolutionizing epicardial access. Device and procedural specifications along with the underlying physics of needle ablation prove the feasibility of the technology. The regulatory hurdles, human use, and milestones for scaling up to clinical trials are all addressed in the commercialization of the surgical platform. Beyond the indicated use of VT ablation, HeartLander can look toward existing practices and developing regenerative therapies for expanding its customer base.","abstract_has_math":false,"creators":["Gostout, Noah Smith"],"institution":"Case Western Reserve University School of Graduate Studies","degree_name":"Master of Sciences","degree_level":"masters","degree_discipline":"Physics","degree_department":null,"school":null,"contributors":["Caner, Ed"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013-03-08","date_published":"2013-03-08","updated_at":"2026-07-24T03:35:52Z","subjects":["Entrepreneurship","Surgical robots","cardiac surgery","commercialization","feasibility","noah gostout","gostout","heartlander"],"languages":["English"],"rights":["unrestricted","This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://rave.ohiolink.edu/etdc/view?acc_num=case1354824891","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Caner, Ed"]},{"key":"dc:creator","label":"Author","values":["Gostout, Noah Smith"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2013-03-08"]},{"key":"dc:publisher","label":"Institution","values":["Case Western Reserve University School of Graduate Studies / OhioLINK"]},{"key":"dc:type","label":"Dc Type","values":["Electronic Thesis or Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Physics"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Sciences"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Case Western Reserve University School of Graduate Studies"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Entrepreneurship","Surgical robots","cardiac surgery","commercialization","feasibility","noah gostout","gostout","heartlander"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["unrestricted","This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://rave.ohiolink.edu/etdc/view?acc_num=case1354824891"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["It is shown that ventricular tachycardia ablation via the HeartLander Surgical robot is a commercially feasible method for relieving patients from arrhythmia symptoms. HeartLander’s technology meets significant market needs presented by the 450,000 sudden cardiac deaths each year; many were patients for whom ablation was not an option. HeartLander’s robotic platform provides significant benefits per cost savings for hospitals and insurance companies, and significantly reduces VT ablation procedure times. HeartLander’s product shows the potential for both commercial and academic impact by revolutionizing epicardial access. Device and procedural specifications along with the underlying physics of needle ablation prove the feasibility of the technology. The regulatory hurdles, human use, and milestones for scaling up to clinical trials are all addressed in the commercialization of the surgical platform. Beyond the indicated use of VT ablation, HeartLander can look toward existing practices and developing regenerative therapies for expanding its customer base."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","p.71","2.65 MB"]},{"key":"dc:title","label":"Title","values":["HeartLander Surgical Feasibility and Commercialization"]}]}],"canonical_facts":{"dc:contributor":["Caner, Ed"],"dc:creator":["Gostout, Noah Smith"],"dc:date":["2013-03-08"],"dc:description":["It is shown that ventricular tachycardia ablation via the HeartLander Surgical robot is a commercially feasible method for relieving patients from arrhythmia symptoms. HeartLander’s technology meets significant market needs presented by the 450,000 sudden cardiac deaths each year; many were patients for whom ablation was not an option. HeartLander’s robotic platform provides significant benefits per cost savings for hospitals and insurance companies, and significantly reduces VT ablation procedure times. HeartLander’s product shows the potential for both commercial and academic impact by revolutionizing epicardial access. Device and procedural specifications along with the underlying physics of needle ablation prove the feasibility of the technology. The regulatory hurdles, human use, and milestones for scaling up to clinical trials are all addressed in the commercialization of the surgical platform. Beyond the indicated use of VT ablation, HeartLander can look toward existing practices and developing regenerative therapies for expanding its customer base."],"dc:format":["application/pdf","p.71","2.65 MB"],"dc:identifier":["http://rave.ohiolink.edu/etdc/view?acc_num=case1354824891"],"dc:language":["English"],"dc:publisher":["Case Western Reserve University School of Graduate Studies / OhioLINK"],"dc:rights":["unrestricted","This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws."],"dc:subject":["Entrepreneurship","Surgical robots","cardiac surgery","commercialization","feasibility","noah gostout","gostout","heartlander"],"dc:title":["HeartLander Surgical Feasibility and Commercialization"],"dc:type":["Electronic Thesis or Dissertation"],"thesis:degree_discipline":["Physics"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Sciences"],"thesis:institution_name":["Case Western Reserve University School of Graduate Studies"]},"updated_at":"2026-07-24T03:35:52Z"}